Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
ALTA BIOPHARMA PARTNERS III LP
- As of  06/26/22, 01:51:42 PM:   24 Insider Transactions.

Email this page to a friend.

Buy/Sell* 1 Yr Return** Filed Date Subject Symbol Pct Owned Details
S 2015-02-12 16:15:03.0 CHIMERIX INC CMRX 0.4% view
S 2015-02-12 16:13:30.0 CymaBay Therapeutics n/a 7.7% view
S 2015-02-12 16:12:09.0 SUNESIS PHARMACEUTICALS INC SNSS 1.3% view
S 2015-02-12 16:10:22.0 MACROGENICS INC MGNX 6.1% view
B 2014-02-14 15:52:49.0 CymaBay Therapeutics n/a 11.79% view
S 2014-02-14 15:52:02.0 ChemoCentryx CCXI 1.99% view
B 108.30% 2014-02-14 15:50:47.0 CHIMERIX INC CMRX 6.97% view
B 0.50% 2014-02-14 15:49:47.0 MACROGENICS INC MGNX 8.05% view
S 2014-01-14 17:15:23.0 SUNESIS PHARMACEUTICALS INC SNSS 6.66% view
S 2013-02-12 19:53:27.0 THRESHOLD PHARMACEUTICALS INC THLD 3.3% view
B -38.91% 2013-02-12 19:01:49.0 ChemoCentryx CCXI 5.2% view
S 2013-02-04 13:51:21.0 Aegerion Pharmaceuticals AEGR 4.8% view
S 2012-12-19 08:06:41.0 Aegerion Pharmaceuticals AEGR 5.8% view
S 2012-11-29 21:53:39.0 Aegerion Pharmaceuticals AEGR 7.4% view
S 2012-10-22 16:49:51.0 Aegerion Pharmaceuticals AEGR 8.6% view
B 227.10% 2012-01-10 16:42:18.0 THRESHOLD PHARMACEUTICALS INC THLD 6.9% view
B 50.76% 2010-11-08 16:58:38.0 Aegerion Pharmaceuticals AEGR 15.2% view
S 2010-07-09 18:51:29.0 SUNESIS PHARMACEUTICALS INC SNSS 9.9% view
S 2010-02-01 17:20:33.0 THRESHOLD PHARMACEUTICALS INC THLD 6.2% view
S 2009-12-22 18:56:08.0 SUNESIS PHARMACEUTICALS INC SNSS 23.5% view
B -20.51% 2009-11-06 15:31:03.0 SUNESIS PHARMACEUTICALS INC SNSS 28.46% view
B 405.26% 2009-04-13 19:45:26.0 SUNESIS PHARMACEUTICALS INC SNSS 22.7% view
B -19.57% 2008-09-05 18:52:44.0 THRESHOLD PHARMACEUTICALS INC THLD 11.2% view
B -74.59% 2008-02-08 19:24:54.0 SUNESIS PHARMACEUTICALS INC SNSS 8.05% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.
** Since most institutions are long investors, only returns for long transactions are shown here.